BioSpace News Archive

Press Releases

Phase 2 data from the ongoing HIBISCUS study shows promise that investigational etavopivat could reduce the incidence of vaso-occlusive crises in people with sickle cell disease

December 9, 2024
·
8 min read
Nektar Therapeutics Announces NKTR-255 Following CD19-directed CAR-T Therapy Enhanced Complete Response Rates in Patients with Relapsed or Refractory Large B-cell Lymphoma at the 66th Annual ASH Meeting

December 9, 2024
·
8 min read
Press Releases

MiNA Therapeutics Presents New Pre-Clinical Data from Lead Sickle Cell Disease Program at the American Society of Hematology Annual Meeting

December 9, 2024
·
3 min read
Press Releases

New Research from Children’s Hospital of Philadelphia to Transform Standard of Care Across the Globe for Newly Diagnosed Children with B-cell Acute Lymphoblastic Leukemia

December 9, 2024
·
4 min read
Press Releases

City of Hope Scientists Present Innovative Research on How High-Fiber Diets Can Improve Outcomes in Cancer Care

December 9, 2024
·
7 min read
Press Releases

Affimed Announces Positive Results Demonstrating Safety and Efficacy of Acimtamig and AlloNK® Combination in Relapsed/Refractory Classical Hodgkin Lymphoma (R/R cHL) Patients

December 9, 2024
·
6 min read
Press Releases

Datopotamab deruxtecan granted breakthrough therapy designation in US for patients with previously treated advanced EGFR-mutated non-small cell lung cancer

December 9, 2024
·
10 min read
Press Releases

Syndax Announces Additional Positive Data for Revuforj® (revumenib) from AUGMENT-101 Trial in Relapsed or Refractory mNPM1 AML and BEAT AML Frontline Combination Trial

December 9, 2024
·
16 min read
Press Releases

Endo Receives U.S. FDA Approval of Manufacturing Facility in Indore, India

December 9, 2024
·
3 min read
Press Releases

Silence Therapeutics Presents Promising Phase 1 Data in Polycythemia Vera Patients at the American Society of Hematology (ASH) Annual Meeting

December 9, 2024
·
8 min read